Showing results (1-10 of 305) with videos related to
Sort By:
Pageof 31
Journal of Clinical Medicine|July 11, 2020
Minimal Residual Disease in Multiple Myeloma: State of the Art and Future PerspectivesRoberto Mina, Stefania Oliva, Mario BoccadoroExpert Review of Anticancer Therapy|May 17, 2018
A look at treatment strategies for relapsed multiple myelomaGiusy Cetani, Mario Boccadoro, Stefania OlivaCancer Cell International|June 3, 2005
Preclinical evaluation of the proteasome inhibitor bortezomib in cancer therapyMario Boccadoro, Gareth Morgan, Jamie CavenaghJournal of Clinical Medicine|August 23, 2020
Erratum: Mina, R.; et al. Minimal Residual Disease in Multiple Myeloma: State of the Art and Future Perspectives. J. Clin. Med. 2020, 9, 2142Roberto Mina, Stefania Oliva, Mario BoccadoroCancers|October 29, 2020
Diagnostic and Therapeutic Challenges in the Management of Intermediate and Frail Elderly Multiple Myeloma PatientsFrancesca Bonello, Mario Boccadoro, Alessandra LaroccaTherapeutics and Clinical Risk Management|May 14, 2008
Review of thalidomide in the treatment of newly diagnosed multiple myelomaFederica Cavallo, Mario Boccadoro, Antonio PalumboCurrent Hematologic Malignancy Reports|August 19, 2017
Novel Immunotherapies for Multiple MyelomaMattia D'Agostino, Mario Boccadoro, Eric L SmithExpert Opinion on Biological Therapy|August 11, 2017
Systemic virotherapy for multiple myelomaStefania Oliva, Manuela Gambella, Mario Boccadoro, et al.Expert Opinion on Investigational Drugs|May 22, 2020
New drugs in early development for treating multiple myeloma: all that glitters is not goldLuca Bertamini, Francesca Bonello, Mario Boccadoro, et al.Clinical Lymphoma, Myeloma & Leukemia|November 1, 2011
Management of myeloma: an Italian perspectiveBenedetto Bruno, Francesca Gay, Mario Boccadoro, et al.Pageof 31